Pain Compared Between the First and the Second Surgery in Staged BTKA

February 4, 2013 updated by: Kim Mihyun, Seoul National University Bundang Hospital

Comparison of Postoperative Pain in the First and Second Knee in Staged Bilateral Total Knee Arthroplasty: Clinical Evidence That Central Sensitization Increases Systemic Pain Sensitivity

postoperative pain and analgesic consumption between the first and the second surgery would be compared in patients undergoing staged bilateral total knee arthroplasty (BTKA).

Study Overview

Status

Unknown

Conditions

Detailed Description

postoperative pain and analgesic consumption is compared between the first and second total knee arthroplasty (TKA) operation.

Study Type

Observational

Enrollment (Anticipated)

34

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Gyeonggi-Do
      • Seongnam, Gyeonggi-Do, Korea, Republic of, 463-787
        • Recruiting
        • Seoul National University Bundang Hopital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 85 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

patients undergoing elective bilateral staged total knee arthroplasty

Description

Inclusion Criteria:

  • patients undergoing elective bilateral staged total knee arthroplasty at a 1-week interval under spinal anesthesia,
  • age <=85
  • American Society of Anesthesiologists physical status of I to II

Exclusion Criteria: any contraindication to spinal anesthesia or femoral nerve block such as coagulopathy; conversion to general anesthesia; preexisting pain syndrome; abnormal liver function or renal test results; severe heart, liver, or renal disease; history of stroke or neurologic deficits; psychiatric disorder; chronic opioid use; drug dependency; allergy to study medications; inflammatory joint disease; previous surgery on or trauma of the knee; difference in preoperative VAS score of ≥ 20 (at rest and at maximum knee flexion) between each side of the knee; body mass index of ≥ 40 kg/m2; and inability to comprehend the VAS or to use patient-controlled analgesia (PCA.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
BTKA
patients undergoing bilateral staged total knee arthroplasty

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
VAS
Time Frame: from the end of the TKA surgery until postoperative 48 hour
visual analogue scale
from the end of the TKA surgery until postoperative 48 hour

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
analgesic consumption
Time Frame: from the end of the TKA surgery until postoperative 48 hour
patient controlled analgesia (fentanyl)
from the end of the TKA surgery until postoperative 48 hour
rescue analgesic
Time Frame: from the end of the TKA surgery until postoperative 48 hour
ketoprofen
from the end of the TKA surgery until postoperative 48 hour
antiemetics
Time Frame: from the end of the TKA surgery until postoperative 48 hour
antiemetics total amount
from the end of the TKA surgery until postoperative 48 hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Sanghwan Do, PhD, Seoul National University Bundang Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2011

Primary Completion (Anticipated)

February 1, 2013

Study Completion (Anticipated)

March 1, 2013

Study Registration Dates

First Submitted

October 19, 2011

First Submitted That Met QC Criteria

October 20, 2011

First Posted (Estimate)

October 21, 2011

Study Record Updates

Last Update Posted (Estimate)

February 6, 2013

Last Update Submitted That Met QC Criteria

February 4, 2013

Last Verified

February 1, 2013

More Information

Terms related to this study

Other Study ID Numbers

  • TKA bilat pain

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Osteoarthritis

Subscribe